Core Labs -4.5% after missing Q1 numbers, guiding Q2 below consensus

Core Laboratories (CLB) -4.5% AH after reporting Q1 earnings and revenues that came in below Street expectations.

Reservoir Description operations, which focus primarily on offshore complex crude oil projects, posted Q1 revenues of $125M, up slightly from a year ago but less than expected as several deepwater projects were delayed because of projected cost overruns precipitating redesign of production facilities; operating margins rose 40 bps to ~28%.

Production Enhancement operations, which focus primarily on North American tight oil plays, posted Q1 revenues of ~$110M, up 3% Y/Y but lower than expected because of weather disruptions to tight oil operations and delays in deepwater Gulf of Mexico projects; operating margins rose 270 bps to ~35%.

Sees Q2 EPS of $1.48-$1.53 vs. analyst consensus estimate $1.54 and revenue of $280M-$286M vs. consensus $290M; sees FY 2014 EPS of $6.00-$6.25 vs. consensus $6.24 and revenue of $1.155B-$1.175B vs. consensus $1.176B.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs